A detailed history of Carderock Capital Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Carderock Capital Management Inc holds 1,450 shares of JNJ stock, worth $227,258. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,450
Previous 1,500 3.33%
Holding current value
$227,258
Previous $219,000 6.85%
% of portfolio
0.06%
Previous 0.06%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$145.48 - $167.38 $7,273 - $8,369
-50 Reduced 3.33%
1,450 $234,000
Q2 2024

Jul 22, 2024

SELL
$144.38 - $157.78 $14,438 - $15,778
-100 Reduced 6.25%
1,500 $219,000
Q4 2023

Jan 23, 2024

BUY
$145.6 - $158.88 $2,475 - $2,700
17 Added 1.07%
1,600 $250,000
Q3 2023

Oct 23, 2023

BUY
$155.75 - $174.48 $246,552 - $276,201
1,583 New
1,583 $246,000
Q1 2023

Apr 19, 2023

SELL
$151.05 - $180.26 $199,688 - $238,303
-1,322 Reduced 49.48%
1,350 $209,000
Q4 2022

Jan 20, 2023

BUY
$160.2 - $179.79 $87,309 - $97,985
545 Added 25.62%
2,672 $472,000
Q3 2022

Nov 04, 2022

BUY
$161.33 - $179.52 $20,488 - $22,799
127 Added 6.35%
2,127 $347,000
Q2 2022

Jul 21, 2022

SELL
$168.19 - $186.01 $20,014 - $22,135
-119 Reduced 5.62%
2,000 $355,000
Q1 2022

Apr 28, 2022

SELL
$158.14 - $179.59 $34,790 - $39,509
-220 Reduced 9.41%
2,119 $376,000
Q3 2021

Oct 29, 2021

SELL
$161.5 - $179.47 $94,316 - $104,810
-584 Reduced 19.98%
2,339 $378,000
Q2 2021

Jul 30, 2021

SELL
$159.48 - $171.07 $75,753 - $81,258
-475 Reduced 13.98%
2,923 $482,000
Q1 2021

May 07, 2021

BUY
$153.07 - $170.48 $22,654 - $25,231
148 Added 4.55%
3,398 $558,000
Q3 2020

Oct 27, 2020

SELL
$140.38 - $153.83 $149,364 - $163,675
-1,064 Reduced 24.66%
3,250 $484,000
Q2 2020

Aug 04, 2020

SELL
$128.81 - $155.51 $80,506 - $97,193
-625 Reduced 12.65%
4,314 $607,000
Q1 2020

May 11, 2020

SELL
$111.14 - $153.99 $11,114 - $15,399
-100 Reduced 1.98%
4,939 $648,000
Q4 2019

Feb 04, 2020

SELL
$127.5 - $146.44 $6,375 - $7,322
-50 Reduced 0.98%
5,039 $735,000
Q3 2019

Oct 24, 2019

BUY
$126.95 - $142.14 $6,347 - $7,106
50 Added 0.99%
5,089 $658,000
Q2 2019

Jul 15, 2019

SELL
$131.15 - $144.24 $6,557 - $7,212
-50 Reduced 0.98%
5,039 $702,000
Q1 2019

Apr 23, 2019

SELL
$125.72 - $139.79 $1,382 - $1,537
-11 Reduced 0.22%
5,089 $711,000
Q4 2018

Feb 14, 2019

SELL
$122.84 - $147.84 $20,514 - $24,689
-167 Reduced 3.17%
5,100 $658,000
Q2 2018

Jul 16, 2018

SELL
$119.4 - $131.76 $133,489 - $147,307
-1,118 Reduced 17.51%
5,267 $639,000
Q1 2018

Apr 27, 2018

SELL
$125.1 - $148.14 $12,510 - $14,813
-100 Reduced 1.54%
6,385 $818,000
Q4 2017

Jan 25, 2018

SELL
$131.22 - $143.62 $91,985 - $100,677
-701 Reduced 9.76%
6,485 $906,000
Q2 2017

Aug 10, 2017

BUY
N/A
7,186
7,186 $951,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Carderock Capital Management Inc Portfolio

Follow Carderock Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carderock Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Carderock Capital Management Inc with notifications on news.